Preeclampsia

JGL Ramos, N Sass, SHM Costa - Revista Brasileira de …, 2017‏ - thieme-connect.com
The authors review hypertensive disease during pregnancy with an academic and practical
view, and using the best evidence available. This disease, which is the most important …

Current best practice in the management of hypertensive disorders in pregnancy

R Townsend, P O'Brien, A Khalil - Integrated blood pressure control, 2016‏ - Taylor & Francis
Preeclampsia is a potentially serious complication of pregnancy with increasing significance
worldwide. Preeclampsia is the cause of 9%–26% of global maternal mortality and a …

Placental growth factor testing to assess women with suspected pre-eclampsia: a multicentre, pragmatic, stepped-wedge cluster-randomised controlled trial

KE Duhig, J Myers, PT Seed, J Sparkes, J Lowe… - The Lancet, 2019‏ - thelancet.com
Background Previous prospective cohort studies have shown that angiogenic factors have a
high diagnostic accuracy in women with suspected pre-eclampsia, but we remain uncertain …

EASL Clinical Practice Guidelines on the management of liver diseases in pregnancy

C Williamson, M Nana, L Poon, L Kupcinskas… - Journal of …, 2023‏ - Elsevier
Liver diseases in pregnancy comprise both gestational liver disorders and acute and chronic
hepatic disorders occurring coincidentally in pregnancy. Whether related to pregnancy or …

[HTML][HTML] Prediction of adverse maternal outcomes from pre-eclampsia and other hypertensive disorders of pregnancy: a systematic review

UV Ukah, DA De Silva, B Payne, LA Magee… - Pregnancy …, 2018‏ - Elsevier
Background The hypertensive disorders of pregnancy are a leading cause of maternal and
perinatal mortality and morbidity. The ability to predict these complications using simple tests …

[HTML][HTML] Preventing deaths due to the hypertensive disorders of pregnancy

P Von Dadelszen, LA Magee - Best practice & research Clinical obstetrics …, 2016‏ - Elsevier
Highlights•The contribution of pregnancy hypertension to maternal mortality is almost
certainly under-estimated.•Solutions relate to both societal and medical interventions.• …

Assessment of the fullPIERS risk prediction model in women with early-onset preeclampsia

UV Ukah, B Payne, JA Hutcheon, JM Ansermino… - …, 2018‏ - ahajournals.org
Early-onset preeclampsia is associated with severe maternal and perinatal complications.
The fullPIERS model (Preeclampsia Integrated Estimate of Risk) showed both internal and …

[HTML][HTML] Temporal and external validation of the fullPIERS model for the prediction of adverse maternal outcomes in women with pre-eclampsia

UV Ukah, B Payne, H Karjalainen, E Kortelainen… - Pregnancy …, 2019‏ - Elsevier
The fullPIERS model is a risk prediction model developed to predict adverse maternal
outcomes within 48 h for women admitted with pre-eclampsia. External validation of the …

External validation of the fullPIERS model for predicting adverse maternal outcomes in pregnancy hypertension in low-and middle-income countries

UV Ukah, B Payne, T Lee, LA Magee… - …, 2017‏ - ahajournals.org
The hypertensive disorders of pregnancy are leading causes of maternal mortality and
morbidity, especially in low-and middle-income countries. Early identification of women with …

Blood-based cerebral biomarkers in preeclampsia: Plasma concentrations of NfL, tau, S100B and NSE during pregnancy in women who later develop preeclampsia-A …

L Bergman, H Zetterberg, H Kaihola, H Hagberg… - PLoS …, 2018‏ - journals.plos.org
Objective To evaluate if concentrations of the neuronal proteins neurofilament light chain
and tau are changed in women develo** preeclampsia and to evaluate the ability of a …